Sunpointe, LLC Atea Pharmaceuticals, Inc. Transaction History
Sunpointe, LLC
- $154 Billion
- Q2 2024
A detailed history of Sunpointe, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Sunpointe, LLC holds 11,943 shares of AVIR stock, worth $46,099. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,943
Previous 11,943
-0.0%
Holding current value
$46,099
Previous $48.3 Million
18.07%
% of portfolio
0.03%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
120Shares Held
49.6MCall Options Held
108KPut Options Held
327K-
Black Rock Inc. New York, NY9.24MShares$35.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.15MShares$23.7 Million0.71% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.54MShares$21.4 Million14.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$18.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.08MShares$15.7 Million2.01% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $321M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...